Tag: COVID-19

The WHO Global framework has been designed as a resource for scientists, researchers, public health authorities, and investigators in Member States.

WHO move to understand origins of new or re-emerging pathogens

0
With the support of the Scientific Advisory Group for the Origins of Novel Pathogens (SAGO), the World Health Organization (WHO) has published a global...
ICMR

No link between sudden deaths and Covid vaccine: ICMR  

0
A study conducted by Indian Council of Medical Research (ICMR) concludes that Covid-19 vaccination did not increase the risk of sudden deaths among young...
Covid-19

Covid-19’s Pirola variant sparks concern

0
A new, highly mutated Covid-19 variant, BA.2.86, referred to as Pirola, has got healthcare authorities worldwide worried. According to the Independent, doctors have warned that...
covid

Long Covid has disabling effects on hip joints

0
Acute Covid-19 infection can manifest in many ways from nominal symptoms to catastrophic organ failure. It can also cause long-term effects, cumulatively known as...
Covid

WHO chief warns of disease deadlier than Covid

0
The world has to start preparing for a disease even deadlier than Covid-19, World Health Organization (WHO) director-general Tedros Adhanom Ghebreyesus has warned. Tedros on...
Covid-19

Covid-19 no longer a global health emergency: WHO

0
The World Health Organization (WHO) has said that Covid-19 no longer represents a global health emergency – more than three years after the virus...
Bharat Biotech

Bharat Biotech’s nasal vaccine to be launched on 26 January

0
Vaccine manufacturer Bharat Biotech will launch its intranasal Covid-19 vaccine iNCOVACC on 26 January, Republic Day, the company’s CMD Krishna Ella announced. The Central Drugs...
Covid

Covid-19 scare: Govt tells pharma cos to maintain stocks

0
In the wake of the global rise in Covid-19 cases, the Indian government has asked pharma companies to ensure adequate stocks of all drugs,...
iNCOVACC

Bharat Biotech’s nasal Covid vaccine to roll out in January

0
Bharat Biotech’s intranasal Covid-19 vaccine – the iNCOVACC (BBV154) – will be sold for ₹325 per dose at government hospitals, and for ₹800 in...
Hibiocy’s Vaill Covitrap anti-CoV nasal spray.

Aptar Pharma’s multidose device delivers anti-CoV nasal spray

0
Aptar Pharma, a global leader in drug delivery systems, services, and active material science solutions, has announced that its VP7 nasal multidose device is...

This function has been disabled for HealthTekPak.

error: Content is protected !!